Applications and Potential of In Silico Approaches for Psychedelic Chemistry
Open accessThe DOI matches its Crossref record; 99 of the 99 references it cites were found in a registry or an index.
Abstract
Molecular-level investigations of the Central Nervous System have been revolutionized by the development of computational methods, computing power, and capacity advances. These techniques have enabled researchers to analyze large amounts of data from various sources, including genomics, in vivo, and in vitro drug tests. In this review, we explore how computational methods and informatics have contributed to our understanding of mental health disorders and the development of novel drugs for neurological diseases, with a special focus on the emerging field of psychedelics. In addition, the use of state-of-the-art computational methods to predict the potential of drug compounds and bioinformatic tools to integrate disparate data sources to create predictive models is also discussed. Furthermore, the challenges associated with these methods, such as the need for large datasets and the diversity of in vitro data, are explored. Overall, this review highlights the immense potential of computational methods and informatics in Central Nervous System research and underscores the need for continued development and refinement of these techniques and more inclusion of Quantitative Structure-Activity Relationships (QSARs).
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures

![Figure 2 Timeline of key events in computational psychedelic sciences [20,21].](https://figures.cochat.ai/paper-figures/9a50d515ec724e5f9299206e965ca211/applications-and-potential-of-in-silico-approaches-for-psychedelic-chemistry-figure-2.jpg)



![Figure 6 Schematic illustration of two proposed mechanisms of aromatic hydroxylation of Tyramine by Cpd 1, as proposed via (a) a Meisenheimer-complex mechanism and (b) a radical [65,66].](https://figures.cochat.ai/paper-figures/774eb1af2a954b6b8c8f5c46e0bdb61a/applications-and-potential-of-in-silico-approaches-for-psychedelic-chemistry-figure-6.jpg)

Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Structure-Activity Relationship (SAR) analysis plays a pivotal role too. It involves studying the relationship between the chemical structure of cosmetic ingredients and their biological activities.”
From The dark side of beauty: an in-depth analysis of the health hazards and toxicological impact of synthetic cosmetics and personal care products (2024) · cites this paper as [126]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“In silico SAR models can predict the potential for a chemical to bind to specific receptors or enzymes, providing insights into mechanisms of action and potential health effects (126).”
From The dark side of beauty: an in-depth analysis of the health hazards and toxicological impact of synthetic cosmetics and personal care products (2024) · cites this paper as [126]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A Second Generation Force Field for the Simulation of Proteins, Nucleic Acids, and Organic Molecules
Cornell, W. D., Cieplak, P., Bayly, C. I., Gould, I. R., Merz, K. M., Ferguson, D. M., Spellmeyer, D. C., Fox, T., Caldwell, J. W., & Kollman, P. A. (1995) · Journal of the American Chemical Society · doi:10.1021/ja00124a002 · Cited by 13,103 · cited 1×
“Timeline of key events in computational psychedelic sciences [20,21].”
BackgroundDewar, M. J. S., Zoebisch, E. G., Healy, E. F., & Stewart, J. J. P. (1985) · Journal of the American Chemical Society · doi:10.1021/ja00299a024 · Cited by 13,074 · cited 1×
“Timeline of key events in computational psychedelic sciences [20,21].”
BackgroundComputational Methods in Drug Discovery
Sliwoski, G., Kothiwale, S., Meiler, J., & Lowe, E. W. (2014) · Pharmacological Reviews · doi:10.1124/pr.112.007336 · Cited by 2,160 · cited 2×
“…at that time, including that some therapeutic-related phenomena such as protein-protein interactions and/or protein-DNA interactions were formidable problems in part since the size of the systems was perhaps beyond, or at best at the limits, of the then generally available computational power [54].”
BackgroundPredicting new molecular targets for known drugs
Keiser, M. J., Setola, V., Irwin, J. J., Laggner, C., Abbas, A. I., Hufeisen, S. J., Jensen, N. H., Kuijer, M. B., Matos, R. C., Tran, T. B., et al. (2009) · Nature · doi:10.1038/nature08506 · Cited by 1,667 · cited 2×
“The extent to which the power and potential of computational approaches have grown is illustrated by the highly cited study by Keiser et al. in 2009 [45].”
BackgroundEstimation of toxic hazard—A decision tree approach
Cramer, G. M., Ford, R. A., & Hall, R. L. (1976) · Food and Cosmetics Toxicology · doi:10.1016/s0015-6264(76)80522-6 · Cited by 1,570 · cited 1×
“…essential tool towards their treat-ment [68]. and valuable part of toxicology since the mid-1970s [73,74] and an extremely important part in the twenty-first century, as Cramer et al. published the first modern approach (intended primarily to prioritize structures for experimental evaluation) [75].”
BackgroundOxygen Activation and Radical Transformations in Heme Proteins and Metalloporphyrins
Huang, X., & Groves, J. T. (2018) · Chemical Reviews · doi:10.1021/acs.chemrev.7b00373 · Cited by 1,037 · cited 1×
“…of dopamine synthesis, instead of following a traditional Meisenheimer-complex mechanism, the mechanism instead involves an initial hydrogen atom transfer from the phenolic hydroxyl group of the initial tyramine substrate to the iron-oxo of the π -cation radical ferryl-oxo compound (Cpd I) [66].”
BackgroundUltra-large library docking for discovering new chemotypes
Lyu, J., Wang, S., Balius, T. E., Singh, I., Levit, A., Moroz, Y. S., O’Meara, M. J., Che, T., Algaa, E., Tolmachova, K., et al. (2019) · Nature · doi:10.1038/s41586-019-0917-9 · Cited by 998 · cited 2×
“In 2019, Lyu et al. [55] examined possible ligands or leads for binding AmpC β -lactamase and the D4 dopamine receptor.”
BackgroundComputer-based de novo design of drug-like molecules
Schneider, G., & Fechner, U. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1799 · Cited by 948 · cited 1×
“The increasing power of computers coupled with computational method development has greatly expanded the potential of this approach for many fields, including the drug discovery process and computer-aided drug design (CADD) [40].”
Muratov, E. N., Bajorath, J., Sheridan, R. P., Tetko, I. V., Filimonov, D., Poroikov, V., Oprea, T. I., Baskin, I. I., Varnek, A., Roitberg, A., et al. (2020) · Chemical Society Reviews · doi:10.1039/d0cs00098a · Cited by 913 · cited 1×
“In general, this objective can be achieved by an ensemble of single-task models or by a single model that can predict more than one activity simultaneously using non-neural or neural net-based techniques, including deep learning, which has become popular in recent years [77,81].”
BackgroundRethinking drug design in the artificial intelligence era
Schneider, P., Walters, W. P., Plowright, A. T., Sieroka, N., Listgarten, J., Goodnow, R. A., Fisher, J., Jansen, J. M., Duca, J. S., Rush, T. S., et al. (2020) · Nature Reviews Drug Discovery · doi:10.1038/s41573-019-0050-3 · Cited by 894
Research works printed but not linked: 2
- Shulgin A.T. Psychotomimetic Drugs: Structure-Activity Relationships Iversen L.L. Iversen S.D. Snyder S.H. Springer Boston, MA, USA 1978 978-1-4757-0510-2
- Gad S.C. QSAR Encyclopedia of Toxicology 3rd ed. Elsevier Inc. Amsterdam, The Netherlands 2014 Volume 4 1 9 9780123864543
Cited by
Alnuqaydan, A. M. (2024) · Frontiers in Public Health · doi:10.3389/fpubh.2024.1439027 · Cited by 84
Alhawarri, M. B., & Olimat, S. (2024) · Current Pharmaceutical Biotechnology · doi:10.2174/0113892010299804240324140017 · Cited by 11
Karabulut, S., Kaur, H., & Gauld, J. W. (2024) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.3c00677 · Cited by 6
Tanouti, I.-A., Ezzemani, W., Ahmad, S., Redouane, S., Charoute, H., Pineau, P., Fellah, H., & Ezzikouri, S. (2025) · In Silico Research in Biomedicine · doi:10.1016/j.insi.2025.100067 · Cited by 1
Sobańska, A. W., Sobański, A. M., & Brzezińska, E. (2026) · Molecules · doi:10.3390/molecules31020212 · Cited by 1
“Such restrictions limit the research using these compounds—human studies are replaced by animal (mainly rodent) models, e.g., head-twitch response assay [16] and in silico investigations [17].”
Metadata
- Authors
- Karabulut, S., Kaur, H., & Gauld, J. W.
- Affiliations
- University of Windsor (CA)
- Pharmala Biotech, 82 Richmond Street E, Toronto, ON M5C 1P1, Canada
- Corresponding author
- Gauld, James W.
- Venue
- Molecules
- Publisher
- MDPI AG
- Published
- 2023-08-09
- Volume
- 28
- Issue
- 16
- Pages
- 5966
- ISSN
- 1420-3049 (ISSN-L)
- PMC
- PMC10459288
- OpenAlex
- W4385697551
- Cited by
- 8
- References
- 99
- Citations by year
- 2026: 4 · 2025: 1 · 2024: 3
- FWCI
- 0.14
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Molecules (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Scholarship at UWindsor (University of Windsor) (submittedVersion)
- Funders
- Natural Sciences and Engineering Research Council (NSERC) of Canada (04840-2018, IT29298)
- MITACS (04840-2018, IT29298)
- Topics
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Drug Discovery › Computational Drug Discovery Methods
- Social Sciences › Psychology › Clinical Psychology › Psychedelics and Drug Studies
- Physical Sciences › Materials Science › Materials Chemistry › Machine Learning in Materials Science
- Keywords
- psychedelics, computational drug discovery, computational chemistry, central nervous system, mental illness, neurological disorders, drug prediction, bioinformatics, prediction model, QSAR
- MeSH terms
- Central Nervous System, Drug Compounding, Hallucinogens, Computational Biology, Genomics
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Applications and Potential of In Silico Approaches for Psychedelic Chemistry. https://app.cochat.ai/papers/10.3390/molecules28165966
- The paper
- Karabulut, S., Kaur, H., & Gauld, J. W. (2023). Applications and Potential of In Silico Approaches for Psychedelic Chemistry. Molecules. https://doi.org/10.3390/molecules28165966
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.